Clinical Trial - Trial jRCT2071230002
Access comprehensive clinical trial information for jRCT2071230002 through Pure Global AI's free database. This phase not specified trial is sponsored by Bayer Yakuhin, Ltd. and is currently Completed. The study focuses on Chronic kidney disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2071230002
Completed
Trial Details
Japan Registry Clinical Trial • jRCT2071230002
Untitled Trial
Single and multiple dose escalation study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of BAY 3283142 given as oral tablets in Japanese healthy male participants in a randomized, placebo controlled, single blind, group comparison design
Study Focus
Interventional
Sponsor & Location
Bayer Yakuhin, Ltd.
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Chronic kidney disease
Chronic kidney disease, unspecified
Chronic kidney disease, stage 1
Chronic kidney disease, stage 4
Chronic kidney disease, stage 2
Data Source
Japan Registry Clinical Trial
jRCT2071230002
Non-Device Trial